Healthcare entity
Coverage clusters in medical-devices, which accounts for 4 of those 5, with the remainder spread across 1 other category. They are less corroborated than the beat average, carrying 2.2 original sources each against 3.6 for the same window. Of the tracked stories, 2 of 5 also mention Cologuard, the most common co-covered peer.
Last mentioned: Aug 27, 2026
Entity pulse
Coverage balance Positive coverage leads. Positive coverage exceeds negative coverage by 20 percentage points.
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
Coverage clusters in medical-devices, which accounts for 4 of those 5, with the remainder spread across 1 other category. They are less corroborated than the beat average, carrying 2.2 original sources each against 3.6 for the same window. Of the tracked stories, 2 of 5 also mention Cologuard, the most common co-covered peer. The 158-day window averages about 0.2 stories each week. Negative sentiment reaches 20% here, compared with 25% across the 624-story beat baseline for the same window. The average consequence score is 6, matching the 6 beat baseline for this window. Abbott Laboratories appears in 5 tracked Healthcare stories published from March 23, 2026 through August 27, 2026.
Computed from the 5 stories linked to this entity, with beat comparisons drawn from all 624 Healthcare stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering Abbott Laboratories. Shared-story counts are live from our verified record — not editorial picks.
MiniMed scheduled to report fiscal Q1 2027 results
MiniMed Group will report its fiscal Q1 2027 results, the first earnings check after the MiniMed Flex U.S. launch.
MiniMed announces U.S. commercial shipping of MiniMed Flex with Abbott Instinct
MiniMed Group says its Flex automated insulin delivery system is now shipping in the U.S. integrated with Abbott's Instinct 15-day continuous glucose sensor.
A cybersecurity incident at Boston Scientific has disrupted order processing and shipping globally, threatening hospitals and surgical centers reliant on its devices. Analysts warn of a 600-700 bps Q3 revenue hit if recovery matches Stryker's three-week timeline. Health leaders must assess supply chain and patient care risks.
Source: CNA · Sahil Pandey
For health system executives, clinical lab directors, and healthcare investors, this comparison is a real-world barometer of whether diversified diagnostic platforms or life sciences recovery will shape vendor and research spending. Abbott's 42% diagnostics jump to $3.09B, driven by Cologuard and Exact Sciences, points to durable non-invasive screening demand. Thermo Fisher's improving pharma and biotech activity signals a potential rebound in research tool budgets.
Source: insidermonkey.com · finance.yahoo.com
The Abbott-MiniMed Flex integration is now shipping in the U.S., pairing Abbott's 15-day Instinct sensor with MiniMed's smallest app-controlled insulin pump. Clinicians and health systems gain a real-world data point of 80% Time in Range, while payers will weigh the combined system's value against entrenched CGM and AID competitors.
Source: insidermonkey.com · finance.yahoo.com
Abbott raises its 2026 profit outlook as medical device sales jump 9% to $5.85B and diabetes care climbs 11%, proving the resilience of advanced cardiac and CGM technologies. The beat and guidance hike signal that hospitals continue to prioritize high-acuity procedures even under volume pressure.
As global diabetes prevalence reaches record highs, the shift toward localized medical device production is driving a surge in glucometer manufacturing plant investments for 2026. This briefing analyzes the cost structures, regulatory hurdles, and technological requirements for establishing high-volume diagnostic production facilities.
Source: openpr.com · openpr.com
Abbott Laboratories is linked from 5 stories on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
